Skip to main content
Clinical Trials/NCT01067703
NCT01067703
Terminated
Phase 3

Remote Ischaemic Preconditioning for Heart Surgery

University Hospital Schleswig-Holstein10 sites in 1 country1,400 target enrollmentDecember 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Myocardial Injury
Sponsor
University Hospital Schleswig-Holstein
Enrollment
1400
Locations
10
Primary Endpoint
Composite of all-cause mortality, non-fatal myocardial infarction, any new stroke, and/or acute renal failure
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effects of Remote Ischaemic Preconditioning on perioperative ischaemic injury in patients undergoing cardiac surgery compared to control intervention.

Detailed Description

Cardiac surgery with cardiopulmonary bypass is associated with a predictable incidence of myocardial, neurological and renal dysfunction. This significant morbidity and mortality is at least partly due to perioperative ischaemia. Remote ischaemic preconditioning (RIPC) is a novel, simple, non-invasive and inexpensive intervention by which ischaemia of non-vital tissue (skeletal muscles) protects remote organs (heart, brain and kidney) from a subsequent sustained episode of ischaemia. The investigators perform a multicenter randomized controlled study to evaluate that RIPC reduces teh severity of perioperative ischaemic injury in patients undergoing cardiac surgery, and results in about 1/3 risk reduction in the occurence of major adverse events.

Registry
clinicaltrials.gov
Start Date
December 2010
End Date
May 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital Schleswig-Holstein
Responsible Party
Principal Investigator
Principal Investigator

Patrick Meybohm

Prof. Dr. Patrick Meybohm

University Hospital Schleswig-Holstein

Eligibility Criteria

Inclusion Criteria

  • patients undergoing heart surgery on cardiopulmonary bypass

Exclusion Criteria

  • age \< 18
  • Emergency cases
  • left ventricular ejection fraction less than 30%
  • current atrial fibrillation
  • Inability to give informed consent
  • preoperative use of inotropics or mechanical assist device
  • severe liver, renal and pulmonary disease
  • recent myocardial infarction (within 7 days)
  • recent systemic infection or sepsis (within 7 days)
  • severe stroke (within 2 months)

Outcomes

Primary Outcomes

Composite of all-cause mortality, non-fatal myocardial infarction, any new stroke, and/or acute renal failure

Time Frame: In-hospital

Time frame until hospital discharge

Secondary Outcomes

  • length of stay on the intensive care unit(Postoperative during hospital stay)
  • total hospital stay(hospital discharge)
  • Occurence of any component of the composite outcome(Postoperative hospital discharge, 3 months, 12 months)
  • new onset of atrial fibrillation(In-hospital)
  • Delirium(Postoperative 24, 48, 72, 96 hrs)

Study Sites (10)

Loading locations...

Similar Trials